Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Ranitidine 150mg tablets among first January price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 23 items for January 2020 prescriptions.

Drug
Strength
Form
Price
Cefalexin
125mg/5ml
oral suspension (100ml)
£1.95
Cefalexin
250mg/5ml
oral suspension (100ml)
£2.25
Colecalciferol
1,000 units
capsules (30)
£10
Desmopressin
200 micrograms
tablets (30)
£19.47
Dexamfetamine
5mg/5ml
sugar-free oral solution (500ml)
£381.63
Frovatriptan
2.5mg
tablets (6)
£10.95
Irbesartan
150mg
tablets (28)
£5.47
Lamotrigine
100mg
sugar-free dispersible tablets (56)
£9.85
Nifedipine
5mg
capsules (90)
£51.95
Nifedipine
10mg
capsules (90)
£65.63
Quinine sulfate
300mg
tablets (28)
£8.47
Ranitidine
150mg
tablets (60)
£4.05
Rivastigmine
1.5mg
capsules (28)
£5.11
Tizanidine
2mg
tablets (120)
£11.90

Do these reflect the prices you have paid in January so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006288

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel